Syndax Pharmaceuticals Eulerpool naujienos

Syndax Pharmaceuticals akcijų naujienos

Syndax Pharmaceuticals stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Syndax Pharmaceuticals naujienas mes pateikiame čia.

• sausio 23 d. ·

  SeekingAlpha
  Kura Oncology: Sentiment Is Too Negative
• sausio 21 d. ·

  SeekingAlpha
  Syndax Looks Tantalizing, But Looks Can Be Deceptive
• sausio 15 d. ·

  Yahoo
  Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
• sausio 10 d. ·

  Yahoo
  Investing in Syndax Pharmaceuticals (NASDAQ:SNDX) five years ago would have delivered you a 53% gain
• sausio 7 d. ·

  Yahoo
  Syndax Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
• gruodžio 9 d. ·

  Yahoo
  Syndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial
• gruodžio 8 d. ·

  Yahoo
  Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting
• gruodžio 4 d. ·

  Yahoo
  Why Is Syndax Pharmaceuticals, Inc. (SNDX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?
• lapkričio 27 d. ·

  Yahoo
  Syndax Announces Participation at the Citi 2024 Global Healthcare Conference
• lapkričio 18 d. ·

  Yahoo
  Syndax secures FDA OK for new kind of leukemia drug